http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101362679-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101362679-B1
titleOfInvention Delayed-Release Formulations of Pranacaic Acid
abstract The present invention provides that at least one layer of the drug 1S, 9S, (RS, 3S) N- (2-ethoxy-5-oxo-tetrafuran-3-yl) -6,10-dioxo-9- (isoquinoline -1-Oilamino) -1,2,3,4,7,8,9,10-octahydro-6-H-pyridazino [1,2-a] [1,2] diazepine-1- Rapidly release carboxamides and / or salts or derivatives and acids and at least one layer is drug 1S, 9S, (RS, 3S) N- (2-ethoxy-5-oxo-tetrafuran-3-yl ) -6,10-dioxo-9- (isoquinoline-1-oylamino) -1,2,3,4,7,8,9,10-octahydro-6-H-pyridazino [1, 2-a] [1,2] diazepine-1-carboxamide and / or salts or derivatives thereof and two or more layers which release the acid in a delayed manner, autoimmune disease, type I and type II diabetes And delayed release tablets for the treatment of rheumatoid arthritis, osteoarthritis and / or psoriasis.n n n n Sustained release tablets, pranacaic acid, layered tablets, sustained release layers, rapid release layers
priorityDate 2005-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005013863-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18612470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11698902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415854428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419761398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426553864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407559142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844

Total number of triples: 32.